Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes management, whilst phenterminea sympathomimetic appetite suppressantis not authorised by the MHRA for use in the UK
Peptide Therapy Explore physician-guided Ipamorelin peptide therapy consultations in South Florida for eligible patients interested in recovery support, healthy aging, wellness optimization, sleep quality, body composition goals, and personalized peptide therapy programs
The dramatic results patients show off in countless before-and-after photos have made them wildly popular
Weight-Loss Goal Management: Only a third (33%) of healthcare providers are gradually weaning patients off weight loss medications once theyve achieved their goal weight and less than a third (31%) are prescribing lower doses once the weight goal has been achieved
It may not be suitable if: You have one of the contraindicating conditions above
These are research-context figures, not clinical prescribing recommendations
